There is important nosologic utility in staging chronic kidney disease (CKD) based on estimates of glomerular filtration rate (GFR). These equations have been optimized for estimating GFR at a single point in time. Risk assessment models used for prognosis of specified outcome events have commonly incorporated estimated GFR (eGFR), but the validity of this approach has not been evaluated. The current objective is to evaluate the risk of all-cause mortality over a 10-year follow-up period with multivariable-adjusted Cox regression analysis, comparing CKD stages based on eGFR to Cockcroft-Gault estimated creatinine clearance (eCrCl). There were significant differences between Stage 3A and Stage 3B-5 hazard ratios for all-cause mortality (p = 0.003) using eCrCl categories, but not for the same eGFR categories (p = 0.241). Discrimination analysis showed that a clinically significant difference (relative integrated discrimination improvement 778.6%; p = 0.001) was observed between the 2 models for the age strata <= 64. While eGFR is more precise and accurate than the Cockcroft Gault equation for estimating measured GFR at a single point in time, eGFR does not perform as well as eCrCl for assessing risk of all-cause mortality over 10-year follow-up intervals. (C) 2016 S. Karger AG, Basel
机构:
Univ Witwatersrand, Fac Hlth Sci, Sch Clin Med, Johannesburg, South AfricaUniv Witwatersrand, Fac Hlth Sci, Sch Clin Med, Johannesburg, South Africa
机构:
Kobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan
Grad Sch Med, Kobe, Hyogo, JapanKobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan
Funakoshi, Yohei
Fujiwara, Yutaka
论文数: 0引用数: 0
h-index: 0
机构:
Kobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan
Grad Sch Med, Kobe, Hyogo, JapanKobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan
Fujiwara, Yutaka
Kiyota, Naomi
论文数: 0引用数: 0
h-index: 0
机构:
Kobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan
Grad Sch Med, Kobe, Hyogo, JapanKobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan
Kiyota, Naomi
Mukohara, Toru
论文数: 0引用数: 0
h-index: 0
机构:
Kobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan
Grad Sch Med, Kobe, Hyogo, Japan
Kobe Univ Hosp, Ctr Canc, Kobe, Hyogo, JapanKobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan
Mukohara, Toru
Shimada, Takanobu
论文数: 0引用数: 0
h-index: 0
机构:
Kobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan
Grad Sch Med, Kobe, Hyogo, JapanKobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan
Shimada, Takanobu
Toyoda, Masanori
论文数: 0引用数: 0
h-index: 0
机构:
Kobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan
Grad Sch Med, Kobe, Hyogo, JapanKobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan
Toyoda, Masanori
Imamura, Yoshinori
论文数: 0引用数: 0
h-index: 0
机构:
Kobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan
Grad Sch Med, Kobe, Hyogo, JapanKobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan
Imamura, Yoshinori
Chayahara, Naoko
论文数: 0引用数: 0
h-index: 0
机构:
Kobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan
Grad Sch Med, Kobe, Hyogo, JapanKobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan
Chayahara, Naoko
Umezu, Michio
论文数: 0引用数: 0
h-index: 0
机构:
Grad Sch Med, Kobe, Hyogo, Japan
Kobe Univ Hosp, Div Nephrol, Dept Med, Kobe, Hyogo, JapanKobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan
Umezu, Michio
Otsuki, Naoki
论文数: 0引用数: 0
h-index: 0
机构:
Grad Sch Med, Kobe, Hyogo, Japan
Kobe Univ Hosp, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo, JapanKobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan
Otsuki, Naoki
Nibu, Ken-ichi
论文数: 0引用数: 0
h-index: 0
机构:
Grad Sch Med, Kobe, Hyogo, Japan
Kobe Univ Hosp, Dept Otolaryngol Head & Neck Surg, Kobe, Hyogo, JapanKobe Univ Hosp, Div Med Oncol Hematol, Dept Med, Kobe, Hyogo, Japan